Global Search | Novartis

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 2974 results

Clinical Trials / Jun 25, 2026

Study of Out of Specification for Tisagenlecleucel
Clinical Trials / Aug 01, 2024

Kesimpta Pregnancy and Infant Safety Study Using Real World Data
Clinical Trials / Jul 14, 2026

Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
Clinical Trials / Jan 14, 2025

Regulatory Post-Marketing Surveillance Study for Brolucizumab
Clinical Trials / Jul 30, 2025

Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria
Clinical Trials / Jun 03, 2026

A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)
Clinical Trials / Jul 08, 2026

Secukinumab Open Label Roll-over Extension Protocol
Clinical Trials / Jun 26, 2026

Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
Press release / Dec 19, 2025

Novartis and US government reach agreement on lowering drug prices in the US

Novartis agrees to take actions aimed at meeting US Administration priorities for drug pricingAdditional Novartis medicines will be made available through direct-to-patient platforms in 2026Company…
Press release / Oct 29, 2025

Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren’s disease Phase III trials

NEPTUNUS-1 and NEPTUNUS-2 achieved primary objective of reduced disease activity and provided clinically meaningful benefit1 Data showed consistent improvements across secondary…

‹ Previous page
1
…
19
20
21
22
23
24
25
…
298
› Next page